P ulmonary embolism (PE) is associated with significant morbidity and mortality in the pediatric population (estimated to be~10%). 1, 2 According to National Hospital Discharge Survey data, PE in the general pediatric population has an estimated annual incidence of 0.9 per 100,000 patients per year. 3 However, increasing evidence demonstrates that the incidence of venous thromboembolism in the pediatric population is increasing. [4] [5] [6] In hospitalized children, the estimated prevalence of PE ranges from 8.6 to 57 per 100,000 patients. 6, 7 An increase in the medical complexity of pediatric patients 8, 9 as well as increased recognition due to the use of advanced imaging modalities such as computed tomography (CT) pulmonary angiography have been accompanied by higher rates of diagnosing PE in pediatric patients. D-dimer is used to aid clinicians in the diagnosis of PE in adults. However, D-dimer has not been validated in pediatric patients and the role of D-dimer in evaluating pediatric patients for a PE is unknown. Avoidance of unnecessary radiation in pediatric patients is desirable to decrease the lifetime risk of malignancy. Clinicians must balance the risk of radiation with the desire not to miss a PE. D-dimer may be useful in this context.
The quantitative D-dimer assay is commonly used to help rule out the diagnosis of PE in adults. The assay measures products of cross-linked fibrin and represent ongoing activation of hemostasis. The sensitivity of a positive D-dimer assay ranges from 80% to 100% for PE in adults. 10 A normal D-dimer coupled with a non-high pretest probability can rapidly and inexpensively rule out PE in adults and may reduce unnecessary imaging. 11, 12 To our knowledge, only three prior studies have specifically evaluated and reported the sensitivity and specificity of the D-dimer assay in a pediatric population. Kanis et al. 13 reported a positive (230 ng/mL or 500 ng/mL) D-dimer sensitivity of 100% (95% CI = 89%-100%) and specificity 58% (95% CI = 54%-63%) for PE, analyzing 34 PE patients from a cohort of 526 patients between the ages of 5 to 17 years. Hennelly et al.
14 reported a positive (>500 ng/mL) D-dimer sensitivity of 79% (95% CI = 60%-91%) and specificity of 69% (95% CI = 65%-94%) for PE, analyzing 36 PE patients from a cohort of 561 patients < 22 years of age. Neither of these studies compared D-dimer in pediatric patients with only radiographically confirmed PEpositive and PE-negative patients. 13, 14 Finally, Lee et al. 15 compared D-dimer in pediatric patients with only radiographically confirmed PE-positive and PEnegative patients. These investigators examined 25 CTconfirmed PE patients < 19 years of age with a D-dimer test result, of whom 22 of 25 (88%) had a positive (>800 ng/mL) D-dimer. Of those patients with a CT negative for PE with an available D-dimer result, D-dimer was positive in 93 of 107 (87%). 15 This study aims to better characterize the role of the D-dimer assay in pediatric patients, by comparing D-dimer levels between patients diagnosed with a radiographically confirmed PE and those from a highrisk control group in whom PE was suspected but ruled out by negative imaging for PE. The study also evaluates the impact of PE location on D-dimer and, in this hypothesis-generating study, the discriminative value of various thresholds for D-dimer.
METHODS
This case-control chart review was approved by the hospital institutional review board. In keeping with the American Academy of Pediatrics definition, "pediatric" patient in this study refers to individuals 21 years of age or younger. 16 Patients ≤ 21 years of age with a PE were identified by querying central patient databases using International Classification of Diseases Ninth and Tenth revision (ICD-9 and -10) codes for PE. Patient records were indexed from a large academic quaternary care hospital and emergency department (ED) in addition to 15 community hospitals and EDs across two states within a single hospital system, between January 1998 and December 2016. Paper and electronic medical records were reviewed for the presence of a final radiologist-written report of PE by CT or high-probability ventilation/perfusion scintigraphy (V/Q scan). Patients who presented prior to widespread adoption of the electronic medical record system had the majority of their records previously transcribed into electronic format and were also located using ICD-9 codes. After these patients were located, their paper charts were manually pulled for review. Patients were excluded if the record of the PE encounter was unavailable or if patients were diagnosed with a potentially confounding etiology, i.e., septic, amniotic, fat, or air embolism.
The pediatric control group (PE-negative) consisted of patients who were suspected of having a PE but for whom appropriate imaging did not demonstrate PE. These patients were identified by querying a central patient database for patients ≤ 21 years of age with ICD-9 and -10 procedure codes for CT and D-dimer within a 48-hour time frame of the patient's encounter. Patients were excluded if the CT was indeterminate or limited by inadequate contrast administration or respiratory motion artifact.
Eighty-eight PE-positive adolescent patients with D-dimer results were matched 1:1 to 88 PE-negative patients. Matching was based on age (within a year), sex, and race. bioM erieux's VIDAS and Stago's STALiatest D-dimer assays were used starting in 1998 until transitioning to the Siemens INNOVANCE advanced D-dimer assay in 2011.
Central PE was defined as PE in either the right or the left main pulmonary artery. Lobar PE was defined as PE in the right or left lobar arteries. Distal PE was defined as a PE in the segmental or subsegmental arteries. American Heart Association guidelines defined massive PE as accompanying systolic blood pressure < 90 mm Hg for > 15 mins or requiring vasopressor support. Submassive PE was defined as producing right heart strain, dilation, dysfunction, or ischemia. 17 Descriptive statistics were calculated for all variables. Continuous variables presented as mean AE standard deviation and categorical variables as count (%). PE-positive and PE-negative patients were compared with respect to continuous variables using independent-sample t-tests (assuming unequal variances) or Wilcoxon rank-sum tests and categorical variables using chi-square tests or Fisher's exact tests as appropriate. Statistical analyses were performed utilizing SAS JMP Pro version 13.
RESULTS
Cases were derived from an initial query of 542 patients with ICD-9 and -10 codes for PE. From these 542 patients, 88 had both radiographic confirmation of PE and D-dimer results available. These 88 patients were included in our study as cases ("PE-positive"): 94.3% (83/88) PE-positive patients had a CT positive for PE and 5.7% (5/88) had high-probability V/Q (Figure 1 ).
Controls were derived from an initial query of 1,098 pediatric patients suspected of PE. Of these 1,098 patients, 88 patients with both a CT negative for PE and available D-dimer were included in our study as controls ("PE-negative"). PE-negative patients were matched 1:1 to PE-positive cases by age (within 1 year), sex, and race ( Figure 1) .
Ages of PE-positive patients ranged from 13 to 21 years versus 12 to 21 years for PE-negative patients. PE-positive and PE-negative patients had a similar distribution of sex and race (72% female, 60% Caucasian, 35% African American, 5% other races [Asian, Hispanic, Middle-Eastern, and unknown]; Table 1 ). The study population consisted mostly of adolescents; i.e., 66 of 88 (75%) of study patients were between the ages of 19 and 21. Most patients less than 13 years old were excluded due to having been diagnosed with a septic embolism ( Table 1) .
Mean D-dimer was significantly (p < 0.001) higher in PE-positive versus PE-negative patients (3,256 ng/mL vs. 690 ng/mL; Figure 2 ). PE-positive female patients had a significantly higher mean D-dimer than PE-negative female patients (2,869 ng/mL vs. 1,380 ng/mL, p = 0.003). PE-positive male patients also had a significantly higher mean D-dimer compared to PE-negative males (4,288 ng/mL vs. 881 ng/mL, p = 0.023). No significant difference was found between D-dimer levels of PE-positive females and PE-positive males nor between PE-negative females and PE-negative males.
Pulmonary embolism-positive Caucasian patients had a significantly higher mean D-dimer than PE-negative Caucasian patients (2,736 ng/mL vs. 1,172 ng/ mL, p < 0.002). PE-positive African American patients had a higher mean D-dimer compared to PE-negative African American patients (3,957 ng/mL vs. 1,463 ng/mL). No significant difference was found between D-dimer levels of PE-positive Caucasians and PE-positive African Americans nor PE-negative Caucasians and PE-negative African Americans.
Mean D-dimer levels did relate to PE location. Patients with a massive or submassive PE had the highest mean D-dimer levels (8,742 ng/mL), followed by patients with PE in the central (4,795 ng/mL), lobar (3,758 ng/mL), and distal (2,327 ng/mL) branches (Figure 3 ). D-dimer levels in all locations except for lobar were significantly different when compared to mean D-dimer levels in PE-negative patients.
Seventy A positive D-dimer (≥500 ng/mL) had a sensitivity of 90%, specificity of 16%, and positive likelihood ratio of 1.1. A D-dimer with a positive threshold ≥ 750 ng/ mL had a sensitivity of 82%, specificity of 53%, and positive likelihood ratio of 1.8. A D-dimer with a High-probability V/Q and D-dimer
(6)
Data are reported as n (%). PE = pulmonary embolism; V/Q = ventilation/perfusion. positive threshold ≥ 1,000 ng/mL had a sensitivity of 67%, specificity of 67%, and positive likelihood ratio of 2.2 ( Table 2) . Concordance indices using these various D-dimer threshold values showed little discriminative value of D-dimer between PE-positive and highsuspicion PE-negative patients for a D-dimer cutoff of 500 ng/mL (c = 0.50), but improved discriminative value for cutoffs of 750 and 1,000 ng/ml (c = 0.68 and c = 0.70, respectively; Figure 5 ).
DISCUSSION
When confronted with a patient for whom PE represents a possible diagnosis, clinicians must balance the risks of irradiation with that of missing a potentially fatal diagnosis. This tension is especially true for younger patients, given a lifelong risk of radiation exposure. In the absence of a validated clinical tool, clinicians may use D-dimer to guide further testing in pediatric patients suspected of having a PE; however, this problem is problematic because D-dimer use has not been validated for this population. This study addresses this gap by assessing the diagnostic value of D-dimer in a population of adolescent patients with a radiographically confirmed PE and comparing the diagnostic performance of D-dimer in a control group of high-suspicion patients in whom PE was ruled out by imaging.
The main finding of the study was that mean Ddimer was significantly higher in PE-positive patients compared to PE-negative adolescent patients. Univariate comparisons showed significant differences between PE-positive and PE-negative patients by sex and Caucasian race, although no significant difference in mean D-dimer level was observed between PE-positive and PE-negative African American patients, most likely due to the smaller sample size.
A novel finding is that D-dimer levels in adolescent PE are significantly associated with location. Number of patients at mean D-dimer thresholds. Nine (10.2%) PE-positive patients had a mean D-dimer < 500 ng/mL versus 14 (16%) PE-negative patients. Seventy-nine (90%) PE-positive versus 74 (84.1%) PE-negative patients had D-dimer levels ≥ 500 ng/mL. Seventy-two (82%) PE-positive versus 41(47%) PE-negative patients had D-dimer levels ≥ 750 ng/mL (p < 0.001). Sixty-four (73%) PE-positive versus 29 (33%) PE-negative patients had D-dimer levels ≥ 1,000 ng/mL (p < 0.001). PE = pulmonary embolism. 
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Significantly higher D-dimer levels were found in massive/submassive PE and in central PE compared to PE found in peripheral locations (i.e., lobar, segmental, and subsegmental pulmonary branches). A positive D-dimer at the commonly used adult threshold (≥500 ng/mL) missed nine PE-positive patients and led to further testing in 74 PE-negative patients. If the threshold for a positive D-dimer was increased to ≥750 ng/mL, the number of missed PEpositive patients would increase to 16 and the number of false-positive PE-negative patients would decrease to 41. If the threshold was further increased to ≥1,000 ng/mL, 24 PE-positive patients would be missed. Thus, the positive likelihood ratio significantly increases in accordance with D-dimer levels in adolescents with PE.
The sensitivity of D-dimer for the diagnosis of PE was 90% in this study (95% CI = 82%-95%), which is similar to the sensitivity of D-dimer in adults (80%-100%). 10 Two smaller pediatric studies reported a sensitivity of 79% (95% CI = 60%-91%) in a cohort of 36 PE-positive patients and 525 PE-negative patients 14 and a sensitivity of 100% (95% CI = 89%-100%) in a cohort of 51 PE-positive patients and 526 PE-negative patients. 13 Unlike the current study, however, these two prior studies did not assess high-suspicion PE control groups in which PE was ruled out by imaging. This study also refined the analysis by explicitly excluding patients with septic, air, amniotic, and fat emboli, which are pathophysiologically very different entities. These results suggest that D-dimer can be a sensitive test for PE in pediatric patients. However, the ability of D-dimer to discriminate between PE-positive and highrisk patients without PE at current institutional Ddimer level thresholds is limited, a finding confirming conclusions made in a third prior study by Lee et al. 15 Our study has several unique strengths. First, to our knowledge, this study represents the largest available data set from a cohort of adolescent patients with a radiographically confirmed PE. The large number of PE-positive patients in our study provides the opportunity to examine and detect significant associations between Ddimer levels and likelihood of PE as well as PE location that may have escaped detection in smaller, lower-powered studies. 13, 14, 18 Second, patients in this study were drawn from 15 community hospitals/EDs and one large quaternary hospital/ED over two states, lending greater generalizability. Third, unlike prior studies, patients with septic, air, amniotic, and fat emboli were excluded in this analysis, thereby eliminating the confounding associations that might result from including clinically similar but pathophysiologically distinct entities. 4, 13, 14 To identify those features associated with PE that help to differentiate PE from clinical look-alikes, this study also differs in the comparator group. Importantly, the control group in this study was composed of pediatric patients who were suspected to have a PE, but for whom imaging did not demonstrate PE. With this design, we hoped to capture patients who presented with a clinician-guided pretest probability high enough to warrant imaging, for whom PE was not found to be the ultimate cause of their symptoms. Having a radiographically proven (CT or V/ Q scan) control group provides assurance that control patients truly did not have a PE, compared to previous studies which included patients without radiographic confirmation in their control groups 18, 21 and those without any control group. 4 Choosing control patients deemed higher risk by clinicians (requiring both D-dimer and CT) also provides more focused, discriminatory information that we believe is optimally clinically useful.
LIMITATIONS
Several limitations of this study warrant comment. Most significantly, the analysis was retrospective in design. One consequence of the retrospective design was that prospective probability assessment of PE by clinicians, as by Wells criteria, was not generally available. Such assessment has proven to play an important role in PE diagnosis in adults, and further study of D-dimer used in concert with such assessment in pediatric patients is needed. Also, because we relied on ICD codes to identify patients in this retrospective analysis, it is possible that some patients with PE were missed in this series. Cases could have been missed if the diagnosis of PE was omitted from the electronic record or if a patient expired without a diagnosis. This study represents a cohort of adolescents diagnosed with PE, of whom 66 of 88 (75%) were between the ages of 19 and 21. As such, study results do not generalize to children or infants. Many patients younger than 13 years of age were excluded due to our strict imaging and pathophysiologic inclusion and exclusion criteria; for example, many patients were excluded due to a diagnosis of a septic embolism.
CONCLUSIONS
Mean D-dimer levels were significantly higher in pulmonary embolism-positive patients compared to pulmonary embolism-negative patients. D-dimer levels in adolescent pulmonary embolism patients can be significantly associated with location and clinical presentation, with the highest D-dimer levels found in massive and submassive pulmonary embolism. The positive likelihood ratio for pulmonary embolism increases with increased D-dimer levels in adolescent patients. The sensitivity of D-dimer for pulmonary embolism in our study is similar to that in adult studies. The results of this retrospective study require confirmation in prospective analysis of adolescent pulmonary embolism patients, ideally also including clinician probabilistic estimates of pulmonary embolism likelihood (e.g., Wells criteria).
